653A9443.jpg

Turning wild-type phages into drug-grade ε²Phages® 

What makes PhagoMed’s ε²Phages® special?

PhagoMed creates novel phage genotypes through directed inter-crossings of wild-type phages on our ε² Directed Evolution platform. The resulting ε²Phages® are highly evolved and optimized for therapeutic applications:

  • Optimized for high host range & low resistance formation

  • Only natural inter-crossing techniques used to create ε²Phages® 

  • Bio-availability optimized for the exact treatment setting

  • Broad patent protection secured

Natural phages recombined to create phages with superior phenotype 

Natural phage 3

Natural phage 4

ε²Phage®

Recombinations

PhagoMed Biopharma GmbH

Leberstraße 20

1110 Vienna

Austria

contact@phagomed.com

Imprint & Privacy Policy